Case 1: Patient with Ulcerative Proctitis Experiences Progression of Bowel Involvement
Patients with ulcerative colitis (UC) often receive inadequate or inappropriate treatment. Management of UC is based on the assessment of disease activity, which is represented by both clinical symptoms and mucosal inflammation. This Virtual Practice has been developed to simulate the day-to-day challenges encountered by clinicians who provide care to patients with UC.
Medium: Virtual e-learning module
Commercial Support Statetements: Support for this activity has been provided through educational grants from Janssen Biotech, Inc, administered by Janssen Scientific Affairs and Takeda Pharmaceuticals International, U.S. Region.
Joint Provider: RedMedEd
This activity has been designed to meet the educational needs of gastroenterologists and other health care professionals who are involved in the management of patients with UC.
Upon completion of this activity, participants should be able to:
- Discuss the efficacy, safety, and clinical placement of new and emerging therapies for UC;
- Design effective strategies for managing UC that take into consideration the indications, risks, and benefits of long-term nonbiologic and biologic therapies.